{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:06:25Z","timestamp":1762430785417,"version":"build-2065373602"},"reference-count":40,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["dir"],"DOI":"10.4274\/dir.2025.253361","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:25:26Z","timestamp":1758536726000},"source":"Crossref","is-referenced-by-count":0,"title":["Early prediction of neoadjuvant chemotherapy efficacy among patients with triple-negative breast cancer using an ultrasound-based radiomics nomogram"],"prefix":"10.4274","author":[{"given":"Min-Jia","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ling","family":"Zha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of in-cidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3)229-263. [Crossref]","DOI":"10.3322\/caac.21834"},{"key":"ref1","unstructured":"2. Jiang YZ, Ma D, Suo C, et al. Genomic and Transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35(3):428-440. [Crossref]"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Carey L, Winer E, Viale G, Cameron D, Gianni L. Triple-negative breast cancer: disease entity or title of convenience? Nat Rev Clin Oncol. 2010;7(12):683-692. [Crossref]","DOI":"10.1038\/nrclinonc.2010.154"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer sub-types and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750-2767. [Crossref]","DOI":"10.1172\/JCI45014"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938-1948. [Crossref]","DOI":"10.1056\/NEJMra1001389"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Verma A, Singh A, Singh MP, et al. EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis. Nat Commun. 2022;13(1):7344. [Crossref]","DOI":"10.1038\/s41467-022-35059-x"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Zagami P, Carey LA. Triple negative breast cancer: pitfalls and progress. NPJ Breast Cancer. 2022;8(1):95. [Crossref]","DOI":"10.1038\/s41523-022-00468-0"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Masuda N, Lee SJ, Ohtani S, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376(22):2147-2159. [Crossref]","DOI":"10.1056\/NEJMoa1612645"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164-172. Er-ratum in: Lancet. 2019;393(10175):986. [Crossref]","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Spring L, Greenup R, Niemierko A, et al. Pathologic complete response after neoadjuvant chemotherapy and long-term outcomes among young women with breast cancer. J Natl Compr Cancer Netw. 2017;15(10):1216-1223. [Crossref]","DOI":"10.6004\/jnccn.2017.0158"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Pinder SE, Provenzano E, Earl H, Ellis IO. Laboratory handling and histology reporting of breast specimens from patients who have received neoadjuvant chemotherapy. Histopathology. 2007;50(4):409-417. [Crossref]","DOI":"10.1111\/j.1365-2559.2006.02419.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Adrada BE, Candelaria R, Moulder S, et al. Early ultrasound evaluation identifies excellent re-sponders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer. 2021;127(16):2880-2887. [Crossref]","DOI":"10.1002\/cncr.33604"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT. Multimodality imaging for evaluating response to neoadjuvant chemotherapy in breast cancer. AJR Am J Roentgenol. 2017;208:290-299. [Crossref]","DOI":"10.2214\/AJR.16.17223"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Fowler AM, Mankoff DA, Joe BN. Imaging neoadjuvant therapy response in breast cancer. Ra-diology. 2017;285(2):358-375. [Crossref]","DOI":"10.1148\/radiol.2017170180"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Zhang MQ, Du Y, Zha HL, et al. Construction and validation of a personalized nomogram of ul-trasound for pretreatment prediction of breast cancer patients sensitive to neoadjuvant chemo-therapy. Br J Radiol. 2022;95(1140):20220626. [Crossref]","DOI":"10.1259\/bjr.20220626"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Mayerhoefer ME, Materka A, Langs G, et al. Introduction to radiomics. J Nucl Med. 2020;61(4):488-495. [Crossref]","DOI":"10.2967\/jnumed.118.222893"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749-762. [Crossref]","DOI":"10.1038\/nrclinonc.2017.141"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Jiang M, Li CL, Luo XM, et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast can-cer. Eur J Cancer. 2021;147:95-105. [Crossref]","DOI":"10.1016\/j.ejca.2021.01.028"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Wibmer A, Hricak H, Gondo T, et al. Haralick texture analysis of prostate MRI: utility for differen-tiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015;25(10):2840-2850. [Crossref]","DOI":"10.1007\/s00330-015-3701-8"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Du Y, Zha HL, Wang H, et al. Ultrasound-based radiomics nomogram for differentiation of tri-ple-negative breast cancer from fibroadenoma. Br J Radiol. 2022;95(1133):20210598. [Cross-ref]","DOI":"10.1259\/bjr.20210598"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pre-treatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res BCR. 2017;19(1):57. Erratum in: Breast Cancer Res. 2017;19(1):80. [Crossref]","DOI":"10.1186\/s13058-017-0862-1"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004. Cancer. 2008;112(4):737-747. [Crossref]","DOI":"10.1002\/cncr.23243"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Ma M, Gan L, Liu Y, et al. Radiomics features based on automatic segmented MRI images: prognostic biomarkers for triple-negative breast cancer treated with neoadjuvant chemothera-py. Eur J Radiol. 2022;146:110095. [Crossref]","DOI":"10.1016\/j.ejrad.2021.110095"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of ex-ceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2018;267(5):946-951. [Crossref]","DOI":"10.1097\/SLA.0000000000002313"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Dobruch-Sobczak K, Piotrzkowska-Wr\u00f3blewska H, Klimonda Z, et al. Multiparametric ultra-sound examination for response assessment in breast cancer patients undergoing neoadju-vant therapy. Sci Rep. 2021;11(1):2501. [Crossref]","DOI":"10.1038\/s41598-021-82141-3"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Zheng Q, Yan H, He Y, et al. An ultrasound-based nomogram for predicting axillary node patho-logic complete response after neoadjuvant chemotherapy in breast cancer: Modeling and ex-ternal validation. Cancer. 2024;130(S8):1513-1523. [Crossref]","DOI":"10.1002\/cncr.35248"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Liedtke C, Hatzis C, Symmans WF, et al. Genomic grade index is associated with response to chemotherapy in patients with breast cancer. J Clin Oncol. 2009;27(19):3185-3191. [Crossref]","DOI":"10.1200\/JCO.2008.18.5934"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Hatzis C, Pusztai L, Valero V, et al. A genomic predictor of response and survival following tax-ane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011;305(18):1873-1881. [Crossref]","DOI":"10.1001\/jama.2011.593"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Jung YY, Hyun CL, Jin MS, et al. Histomorphological factors predicting the response to neoadju-vant chemotherapy in triple-negative breast cancer. J Breast Cancer. 2016;19(3):261-267. [Crossref]","DOI":"10.4048\/jbc.2016.19.3.261"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30. Ni P, Li Y, Wang Y, et al. Construction of a nomogram prediction model for the pathological complete response after neoadjuvant chemotherapy in breast cancer: a study based on ultra-sound and clinicopathological features. Front Oncol. 2025;15:1459914. [Crossref]","DOI":"10.3389\/fonc.2025.1459914"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31. Gu J, Tong T, He C, et al. Deep learning radiomics of ultrasonography can predict response to neoadjuvant chemotherapy in breast cancer at an early stage of treatment: a prospective study. Eur Radiol. 2022;32(3):2099-2109. [Crossref]","DOI":"10.1007\/s00330-021-08293-y"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Ra-diology. 2016;278(2):563-577. [Crossref]","DOI":"10.1148\/radiol.2015151169"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Bi WL, Hosny A, Schabath MB, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127-157. [Crossref]","DOI":"10.3322\/caac.21552"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Zheng X, Yao Z, Huang Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11(1):1236. [Crossref]","DOI":"10.1038\/s41467-020-15027-z"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35. Granzier RWY, Ibrahim A, Primakov SP, et al. MRI-based radiomics analysis for the pretreat-ment prediction of pathologic complete tumor response to neoadjuvant systemic therapy in breast cancer patients: a multicenter study. Cancers. 2021;13(10):2447. [Crossref]","DOI":"10.3390\/cancers13102447"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36. Yang M, Liu H, Dai Q, et al. Treatment response prediction using ultrasound-based pre-, post-early, and delta radiomics in neoadjuvant chemotherapy in breast cancer. Front Oncol. 2022;12:748008. [Crossref]","DOI":"10.3389\/fonc.2022.748008"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37. Nougaret S, Tibermacine H, Tardieu M, Sala E. Radiomics: an introductory guide to what it may foretell. Curr Oncol Rep. 2019;21(8):70. [Crossref]","DOI":"10.1007\/s11912-019-0815-1"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Suga M, Nishii R, Miwa K, et al. Differentiation between non-small cell lung cancer and radia-tion pneumonitis after carbon-ion radiotherapy by 18F-FDG PET\/CT texture analysis. Sci Rep. 2021;11(1):11509. [Crossref]","DOI":"10.1038\/s41598-021-90674-w"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Gu J, Tong T, Xu D, et al. Deep learning radiomics of ultrasonography for comprehensively pre-dicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: a multicenter study. Cancer. 2023;129(3):356-366. [Crossref]","DOI":"10.1002\/cncr.34540"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40. Gu J, Polley EC, Denis M, et al. Early assessment of shear wave elastography parameters fore-sees the response to neoadjuvant chemotherapy in patients with invasive breast cancer. Breast Cancer Res. 2021;23(1):52. [Crossref]","DOI":"10.1186\/s13058-021-01429-4"}],"container-title":["Diagnostic and Interventional Radiology"],"original-title":[],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:57:26Z","timestamp":1762430246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dirjournal.org\/articles\/early-prediction-of-neoadjuvant-chemotherapy-efficacy-among-patients-with-triple-negative-breast-cancer-using-an-ultrasound-based-radiomics-nomogram\/doi\/dir.2025.253361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":40,"URL":"https:\/\/doi.org\/10.4274\/dir.2025.253361","relation":{},"ISSN":["1305-3825","1305-3612"],"issn-type":[{"type":"print","value":"1305-3825"},{"type":"electronic","value":"1305-3612"}],"subject":[],"published":{"date-parts":[[2025,9,22]]}}}